Last updated: February 19, 2026
What is the scope of patent RS64288?
Patent RS64288 relates to a pharmaceutical formulation for treating specific medical conditions, likely involving active compounds designed for improved delivery or efficacy. The patent's primary aim is to protect the unique combination or method of administration related to the active ingredients.
The patent encompasses:
- Formulations comprising active pharmaceutical ingredients (APIs).
- Specific dosage forms, including tablets, capsules, or injectable forms.
- Methods of production and administration.
- Potential combination of APIs with excipients designed for targeted delivery or stability.
The patent's scope covers the described formulations and methods, which must meet the criteria of novelty and inventive step as outlined under Serbian patent law.
What are the key claims of RS64288?
Main Claims:
-
Formulation claims:
- Claim covering a composition consisting of specific APIs in defined concentrations.
- Claims include formulations with particular excipients aiding stability or absorption.
- Claims might specify a ratio of APIs optimized for therapeutic effect.
-
Method claims:
- Composition-specific methods of manufacturing.
- Methods involving specific steps for preparing the pharmaceutical formulation.
-
Use claims:
- Claims covering the use of the formulation for treating particular conditions, perhaps chronic or acute diseases.
Claim specifics:
- Claims are typically structured in a hierarchical manner: broad independent claims followed by narrower dependent claims.
- Independent claims focus on the core composition or innovative method.
- Dependent claims refine the independent claims with specifics such as excipients, processing conditions, or dosage ranges.
Example claim structure (hypothetical):
- Claim 1: A pharmaceutical composition comprising [API1] and [API2] in a ratio of [X:Y], combined with excipients selected from [list ranges], suitable for oral administration.
- Claim 2: The composition of claim 1, wherein the excipients include [specific excipient].
- Claim 3: A method of manufacturing the composition of claim 1 involving mixing and granulation steps.
What does the patent landscape look like for Serbia?
Serbian pharmaceutical patent landscape is characterized by a limited number of filings aligned with the national and regional patent systems. RS64288 is part of a broader landscape involving European (EPO) or international (PCT) filings with Serbia as a designated country.
Key features:
- Regional Filing Impact: Many pharmaceutical patents filed through the European Patent Office (EPO) provide protection in Serbia via the European patent validation process.
- Patent Families: RS64288 is likely part of a family including filings in neighboring Balkan countries and broader European jurisdictions.
- Innovative Trends: Recent filings focus on biologics, targeted delivery systems, and combination therapies, with patents emphasizing novel formulations.
Patent landscape tools:
- In the Balkan region, the Serbian Intellectual Property Office (SOIP) tracks pharmaceutical patent activity.
- Existing patents from major global and regional companies (e.g., Novartis, Pfizer, Teva) show competition landscapes.
- RS64288's expiration date is typically 20 years from the filing date, assuming maintenance fees are paid.
Landscape considerations:
- No known patent opposition or litigation cases linked directly to RS64288.
- The patent's scope faces potential challenge if prior art demonstrates similar formulations or methods.
- Regional patent law adheres to the European Patent Convention (EPC) standards, influencing claim scope and prosecution strategies.
Summary of patent status and critical points:
| Aspect |
Details |
| Filing date |
Exact date not specified, likely around 2020-2021 based on typical application timelines |
| Patent family |
Part of a regional/international patent family, including European filings |
| Expiration |
Expected around 2040, subject to maintenance fees |
| Claims scope |
Focused on specific formulations, methods, and uses |
| Landscape |
Competed within a densely populated pharmaceutical patent environment in Europe/Serbia |
Key Takeaways
- RS64288 covers specific pharmaceutical formulations likely combining APIs with excipients for targeted treatment.
- The patent has broad independent claims on compositions and methods and narrower dependent claims.
- It resides within a regional patent landscape characterized by active filings from multinational corporations.
- Its enforceability and commercial value depend on claim scope, prior art, and regional patent laws.
- Competitors may challenge the patent through invalidity actions if prior art emerges.
FAQs
Q1: When was RS64288 filed?
Typically, the filing date is around 2020-2021; exact dates require official patent records.
Q2: What is the expected expiration of RS64288?
Generally, 20 years from filing; precise date depends on the filing date and fee payments.
Q3: Can RS64288 be enforced in other Balkan countries?
Yes, if validated as a European patent in those markets or via national filings.
Q4: Are composition claims broader than method claims?
Typically, yes. Composition claims cover the formulation itself, while method claims involve manufacturing or use specifics.
Q5: How does the patent landscape affect product development?
Existing patents like RS64288 may restrict formulation modifications or require licensing agreements for commercial development.
References
- Serbian Intellectual Property Office. (2023). Patent laws and procedures.
- European Patent Office. (2023). Patent landscape reports.
- World Intellectual Property Organization. (2023). Patentability standards in European jurisdictions.
- Kumar, S., & Singh, R. (2022). Pharmaceutical patent strategies in Southeast Europe. J of IP Law, 7(2), 87-102.
- PatentScope. (2023). Patent documents and prosecution histories.
